7 November 2017
A small clinical trial (PLASMA) by Stanford University School of Medicine in the US has demonstrated the safety of blood-plasma infusions from young donors to patients with mild to moderate...
6 November 2017
The US-based Roswell Park Cancer Institute has begun a Phase I/IIa clinical trial on a new adoptive T-cell therapy for the treatment of various types of advanced cancer.
2 November 2017
Incyte has partnered with AstraZeneca’s biologics research and development division MedImmune to evaluate the combination of epacadostat and Imfinzi (durvalumab) in a Phase III clinical trial to treat non-small cell...
31 October 2017
Boehringer Ingelheim has expanded its strategic partnership with research organisation Sarah Cannon Research Institute to investigate BI 891065 in a Phase I clinical trial to treat patients with solid tumours.
24 October 2017
Canadian company Aurinia Pharmaceuticals is set to commence clinical trials next year for the treatment of renal disorders and keratoconjunctivitis sicca or dry eye syndrome (DES) with its drug candidate,...
23 October 2017
DBV Technologies has reported top-line results from the Peanut EPIT Efficacy and Safety (PEPITES) Phase III clinical trial of Viaskin Peanut conducted in patients aged from four to 11 years...
19 October 2017
French biotechnology firm Acticor Biotech has entered an agreement to study Dutch Authorities' investigational drug candidate ACT017 in a Phase I clinical trial with healthy subjects.
11 October 2017
Non-profit organisation Myeloma UK has initiated an MUK nine clinical trial that will use genetic techniques to stratify therapy for high-risk myeloma patients in the country.
9 October 2017
India-based Sun Pharma Advanced Research (SPARC) has reported top-line results from two Phase III clinical trials of Baclofen GRS to treat spasticity in patients suffering from multiple sclerosis.
4 October 2017
Belgian company Ablynx has reported positive topline results from the Phase III HERCULES trial with caplacizumab to treat acquired thrombotic thrombocytopenic purpura (aTTP).